Carlo Vitagliano
Naples, 80131, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: February 25, 2025
Assessing Urinary Para-Hydroxyphenylacetic Acid as a Biomarker Candidate in Neuroendocrine Neoplasms.
Journal: International journal of molecular sciences
Published: September 13, 2024
Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection.
Journal: Frontiers in oncology
Published: November 28, 2022
Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study.
Journal: ESMO open
Published: October 10, 2022
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 12, 2022
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Journal: Journal of experimental & clinical cancer research : CR
Published: November 01, 2021
Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 30, 2020
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.
Journal: Frontiers in cell and developmental biology
Published: April 01, 2020
Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS-mutated metastatic colorectal cancer: the REVOLUTION study protocol.
Journal: Therapeutic advances in medical oncology
Published: March 27, 2020
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 08, 2019
Last Updated: 09/26/2026